COLOGNE, Germany, March 27, 2025 /PRNewswire/ — From March 25 to 29, 2025, DeepCare, a global leader in dental AI, showcases its Multimodal Dental AI Agent and newly upgraded CBCT AI features at the International Dental Show (IDS 2025) in Cologne, Germany. As the world’s largest and most influential dental exhibition, IDS gathers industry leaders and experts to explore cutting-edge innovations. This marks DeepCare’s second appearance at IDS following its 2023 debut.
DeepCare’s Multimodal Dental AI Agent integrates AI-assisted diagnosis, treatment planning, and patient consultation. It processes six imaging modalities, including panoramic X-rays, CBCT scans, and intraoral photos, detecting nearly 40 dental conditions to help dentists make faster, more informed decisions.
Unlike traditional models, DeepCare AI Agent contextually reasons through clinical cases, leveraging historical data, real-time clinical guidelines, and patient-specific factors such as age, growth stage, and financial constraints. For example, when treating children, it considers developmental factors rather than automatically recommending implants for missing primary teeth.
On the patient side, DeepCare AI Agent offers an intuitive conversational interface, accepting text, voice, or image inputs to recommend specialists, guide treatments, and offer oral self-check tools with personalized health advice.
DeepCare’s enhanced CBCT AI now supports cranium segmentation and reconstruction, making structures like the mandibular fossa and sphenoid bone more visible for precise diagnosis and treatment planning. It also enables automated 3D segmentation of periapical lesions, including maxillary sinus abnormalities, allowing dentists to assess lesion size, shape, and volume with greater accuracy. A new color rendering scheme enhances contrast, making CBCT scans more intuitive and easier to interpret.
“After years of dedicated development, DeepCare now serves tens of thousands of clinics and millions of patients across 60+ countries, including North America, Europe, East Asia, Southeast Asia, the Middle East, North Africa, and South America,” said Dr. Eric Ding, Founder and CEO of DeepCare. “Our Multimodal Dental AI Agent and upgraded CBCT AI features empower dentists with decision-support tools, enhance personalized care, and streamline operations. At IDS 2025, we look forward to collaborating with global experts to drive the future of dental AI.”
About DeepCare
DeepCare is a leading innovator in dental AI, dedicated to delivering comprehensive, patient-centered solutions across the entire dental care journey. For more information, please visit deepcare.com.
Contact
DeepCare PR
contact@deepcare.com
SOURCE DeepCare
Oncovita receives FDA Orphan Drug Designation for its lead oncolytic virus candidate MVdeltaC in the…
Aortic Stenosis is a Serious and Widespread Condition; The AI-ECG Algorithm Offers a Powerful Diagnostic…
Annamycin delivering better performance 7th line than would be expected even in 2nd line for…
Glucotrack to present on next-generation continuous blood glucose monitoring technology in Innovation Hub Poster presentation…
Supports late-stage development and scalable manufacturing for LP-310, a non-steroidal oral rinse therapy for Oral…
LOS ANGELES, June 04, 2025 (GLOBE NEWSWIRE) -- ViaDerma, Inc. (OTC Expert Market: VDRM), a…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="12px" width="12px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
![](data:image/svg+xml;charset=utf-8,<svg height="400px" width="1000px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
